RHBDD1 and non-small cell lung carcinoma: As shown in Fig. 4b, NSCLC patients with higher RHBDD1 expression (median survival time: 76.5 month) in NSCLC tissues had much shorter overall survival rates compared with those of NSCLC patients with lower RHBDD1 expression (median survival time: 94.3 month).